Xin Lang Ji Jin·2025-09-25 06:09Group 1 - The medical sector in A-shares remains active, with the largest medical ETF (512170) rising over 1% and recovering its 5-day moving average, with a trading volume exceeding 480 million yuan [1] - Major stocks in the medical device and CXO sectors saw significant gains, with Mindray Medical rising over 4% and Jiuzhou Pharmaceutical hitting a daily limit before closing nearly 6% higher [1] - Conversely, companies like Meihua Medical and Yingke Medical experienced notable declines [1] Group 2 - The release of the industry standard for medical devices using brain-computer interface technology on September 18 is expected to promote the standardized application of this technology in the medical field [1][3] - Global brain initiatives are driving the development of brain-computer interface technology, with China's first industry standard establishing a unified technical language for the sector [3] - The Shanghai government has announced an action plan to promote the development of high-end medical devices, aiming to add over 500 Class III medical device registration certificates by 2027 and cultivate two hundred billion-level leading enterprises [3] Group 3 - The medical ETF (512170) passively tracks the CSI Medical Index, with its top ten weighted stocks including WuXi AppTec, Mindray Medical, and others [3] - The medical device sector is anticipated to reach a turning point in the second half of the year due to improvements in anti-corruption measures, centralized procurement, and equipment purchasing [3]